Search

everythinglearnresearchcommunity

for

Search:↓

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Women with PCOS have more emotional and body image issues than healthy women.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Many women with hard-to-treat acne also have PCOS.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.